表紙
市場調查報告書

貧血治療藥的全球市場

Anemia Drugs

出版商 Global Industry Analysts, Inc. 商品編碼 912719
出版日期 內容資訊 英文 159 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
貧血治療藥的全球市場 Anemia Drugs
出版日期: 2019年10月01日內容資訊: 英文 159 Pages
簡介

本報告提供全球貧血治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球貧血治療藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • ACCELERON PHARMA
  • AMGEN
  • BAYER AG
  • BIOCON
  • BLUEBIRD BIO
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • GLYCOMIMETICS, INC.
  • REGEN BIOPHARMA INC.

第5章 調查資料

目錄
Product Code: MCP-6192

Anemia Drugs market worldwide is projected to grow by US$18.9 Billion, driven by a compounded growth of 8%. Iron Deficiency Anemia, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$19.3 Billion by the year 2025, Iron Deficiency Anemia will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$651.7 Million to the region's size and clout in the next 5 to 6 years. Over US$563.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Iron Deficiency Anemia will reach a market size of US$923.4 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 12% over the next couple of years and add approximately US$5.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Acceleron Pharma, Inc.; Amgen, Inc.; Bayer AG; Biocon Ltd.; bluebird bio, Inc.; Eli Lilly and Company; GlaxoSmithKline PLC; GlycoMimetics, Inc.; Regen Biopharma Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Anemia Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Anemia Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Anemia Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Anemia Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Iron Deficiency Anemia (Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Iron Deficiency Anemia (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Iron Deficiency Anemia (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Sickle Cell Anemia (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Sickle Cell Anemia (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Sickle Cell Anemia (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Aplastic Anemia (Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Aplastic Anemia (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Aplastic Anemia (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Hemolytic Anemia (Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Hemolytic Anemia (Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Hemolytic Anemia (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Pernicious Anemia (Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Pernicious Anemia (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Pernicious Anemia (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Other Types (Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Other Types (Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Other Types (Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Anemia Drugs Market Share (in %) by Company: 2019 & 2025
    • TABLE 22: United States Anemia Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 23: Anemia Drugs Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 24: United States Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 25: Canadian Anemia Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 26: Canadian Anemia Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 27: Anemia Drugs Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • JAPAN
    • TABLE 28: Japanese Market for Anemia Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 29: Anemia Drugs Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 30: Japanese Anemia Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 31: Chinese Anemia Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 32: Anemia Drugs Historic Market Analysis in China in US$ Million by Type: 2009-2017
    • TABLE 33: Chinese Anemia Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Anemia Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 34: European Anemia Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 35: Anemia Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 36: European Anemia Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 37: European Anemia Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 38: Anemia Drugs Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 39: European Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 40: Anemia Drugs Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 41: French Anemia Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 42: French Anemia Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 43: Anemia Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 44: German Anemia Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 45: German Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 46: Italian Anemia Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 47: Anemia Drugs Historic Market Analysis in Italy in US$ Million by Type: 2009-2017
    • TABLE 48: Italian Anemia Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 49: United Kingdom Market for Anemia Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 50: Anemia Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 51: United Kingdom Anemia Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 52: Spanish Anemia Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 53: Spanish Anemia Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 54: Anemia Drugs Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 55: Russian Anemia Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 56: Anemia Drugs Market in Russia by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 57: Russian Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Anemia Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 59: Anemia Drugs Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 60: Rest of Europe Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 61: Asia-Pacific Anemia Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 62: Anemia Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 63: Asia-Pacific Anemia Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 64: Anemia Drugs Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 65: Asia-Pacific Anemia Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 66: Asia-Pacific Anemia Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 67: Anemia Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 68: Australian Anemia Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 69: Australian Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 70: Indian Anemia Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 71: Indian Anemia Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 72: Anemia Drugs Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 73: Anemia Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 74: South Korean Anemia Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 75: Anemia Drugs Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 76: Rest of Asia-Pacific Market for Anemia Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 77: Anemia Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 78: Rest of Asia-Pacific Anemia Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 79: Latin American Anemia Drugs Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 80: Anemia Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 81: Latin American Anemia Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 82: Latin American Anemia Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 83: Anemia Drugs Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017
    • TABLE 84: Latin American Anemia Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 85: Argentinean Anemia Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 86: Anemia Drugs Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 87: Argentinean Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 88: Anemia Drugs Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 89: Brazilian Anemia Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 90: Brazilian Anemia Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 91: Anemia Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 92: Mexican Anemia Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 93: Mexican Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 94: Rest of Latin America Anemia Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 95: Anemia Drugs Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 96: Rest of Latin America Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 97: The Middle East Anemia Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 98: Anemia Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 99: The Middle East Anemia Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 100: The Middle East Anemia Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 101: The Middle East Anemia Drugs Historic Market by Type in US$ Million: 2009-2017
    • TABLE 102: Anemia Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • IRAN
    • TABLE 103: Iranian Market for Anemia Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 104: Anemia Drugs Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 105: Iranian Anemia Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 106: Israeli Anemia Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 107: Anemia Drugs Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 108: Israeli Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 109: Saudi Arabian Anemia Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 110: Anemia Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017
    • TABLE 111: Saudi Arabian Anemia Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 112: Anemia Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 113: United Arab Emirates Anemia Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 114: Anemia Drugs Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 115: Anemia Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 116: Rest of Middle East Anemia Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 117: Rest of Middle East Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 118: African Anemia Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 119: Anemia Drugs Market in Africa by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 120: African Anemia Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ACCELERON PHARMA
  • AMGEN
  • BAYER AG
  • BIOCON
  • BLUEBIRD BIO
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • GLYCOMIMETICS, INC.
  • REGEN BIOPHARMA INC.

V. CURATED RESEARCH

Back to Top